Press Releases

Two co-presentations with Amgen highlight West's approach to delivering innovative drug delivery solutions for its customers HUNTINGTON BEACH, Calif. , Oct. 17, 2016 /PRNewswire/ --  (Booth #504) -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for

EXTON, Pa. , Oct. 13, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release third quarter 2016 financial results before the market opens on Thursday, October 27,

EXTON, Pa. , Sept. 26, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced it has appointed David A. Montecalvo to serve as Senior Vice President, Global Operations and Supply Chain,

EXTON, Pa. , Sept. 12, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors elected Paolo Pucci to fill the vacancy following the retirement of Anthony Welters .    Mr. Pucci, 54, is Chief Executive Officer of ArQule, Inc.

EXTON, Pa. , Sept. 2, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will be presenting an overview of West's business at three investor conferences in September.  Management will present at the Baird 2016 Global Healthcare Conference, New York,

- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , July 28, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second quarter 2016 and updated financial guidance for the full-year 2016.  Second Quarter 2016 Highlights

EXTON, Pa. , July 14, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release second quarter 2016 financial results before the market opens on Thursday, July 28, 2016 , and

On-body Infusor with Prefilled Cartridge to Deliver Monthly Single Dose of Repatha® (evolocumab) EXTON, Pa. , July 11, 2016 /PRNewswire/ --   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that the U.S.

EXTON, Pa. , July 5, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a third-quarter 2016 dividend of $0.12 per share. The dividend will be paid on August 3, 2016 , to shareholders of record as of July 20, 2016

New, high-quality plungers launched at the 2016 BIO International Convention EXTON, Pa. , June 7, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the availability of the 1-3mL NovaPure®

EXTON, Pa. , June 1, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will present an overview of West's business at the Jefferies Healthcare Conference in New York, NY , on Wednesday, June 8, 2016 at 11:30 a.m. EDT .

EXTON, Pa. , May 4, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will be presenting an overview of West's business at two investor conferences in May. Management will present at the Bank of America Merrill Lynch 2016 Health Care

- Reports Quarterly Sales of $362 Million, Constant-Currency Sales Growth of 10.5% and Adjusted Diluted EPS of $0.53. - Raises Lower-end of Full-year 2016 Sales and Adjusted EPS Guidance Ranges. - Conference Call Scheduled for 9 a.m. EDT Today. EXTON, Pa.

EXTON, Pa. , April 25, 2016 /PRNewswire/ --   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced a strategic investment in NanoPass Technologies Ltd. This investment will provide West with access to NanoPass'

EXTON, Pa. , April 14, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release first quarter 2016 financial results before the market opens on Thursday, April 28, 2016 ,

EXTON, Pa. , March 4, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a second-quarter 2016 dividend of $0.12 per share. The dividend will be paid on May 4, 2016 , to shareholders of record as of April 20, 2016

John Paproski to Retire After 36 Years of Service EXTON, Pa. , March 1, 2016 /PRNewswire/ --   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced Eric Resnick has been appointed to serve as Vice President and

EXTON, Pa. , Feb. 25, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that the Company will host an Analyst and Investor Day on Thursday, March 10, 2016 , from 8:30 a.m. to 12 p.m.

Reports Quarterly Sales of $359.7 Million and Adjusted Diluted EPS of $0.47 -- Annual Sales of $1.4 Billion Generated Adjusted Diluted EPS of $1.83 in 2015 -- Reaffirms 2016 Guidance for 6% to 8% Growth in Net Sales at Constant Currency -- Provides Full-Year 2016 Adjusted Diluted EPS Guidance in

High-performance containment system selected by top biotech company EXTON, Pa. , Feb. 12, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that global biotechnology leader Amgen Inc.

EXTON, PA -- ( Marketwired ) -- 02/11/16 -- West Pharmaceutical Services, Inc. (NYSE: WST) announced today that it will release fourth quarter and full year 2015 financial results before the market opens on Thursday, February 18, 2016 , and will follow with a conference call to discuss the results

EXTON, PA -- ( Marketwired ) -- 02/03/16 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will be presenting an overview of West's business at the LEERINK Partners 5 th Annual Global Healthcare Conference, New York, NY at 10:40 a.m.

Presentation at Drug Delivery Partnerships 2016 will offer best practices for effective patient onboarding with wearable self-injection systems EXTON, Pa. , Jan. 20, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug

EXTON, Pa. , Jan. 12, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced a change to its organization and reporting structure that will support the Company in its next phase of growth and

EXTON, PA -- ( Marketwired ) -- 01/06/16 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will be presenting an overview of West's business and outlook at the 34rd Annual J.P. Morgan Healthcare Conference , San Francisco, CA at 3:00 p.m.

EXTON, PA -- ( Marketwired ) -- 12/17/15 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a first-quarter 2016 dividend of $0.12 per share. The dividend will be paid on February 3, 2016 to shareholders of record as of January 20,

EXTON, Pa. , Nov. 19, 2015 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced it has appointed George L. Miller to serve as Senior Vice President, General Counsel and Corporate Secretary,

Expert panels and presentations offer thought leadership in drug delivery innovation, patient adherence and pharmaceutical manufacturing VIENNA , Nov. 2, 2015 /PRNewswire/ --  (Booth #45-46) – West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable

Reports Sales of $344.5 million and Adjusted Diluted EPS of $0.44 -- Raises Full-Year 2015 Adjusted Diluted EPS to Range of $1.79 to $1.84 -- Conference Call Scheduled for 9 a.m. Today EXTON, PA -- ( Marketwired ) -- 10/29/15 -- West Pharmaceutical Services, Inc.

EXTON, PA -- ( Marketwired ) -- 10/22/15 -- West Pharmaceutical Services, Inc. (NYSE: WST) announced today that it will release third quarter 2015 financial results before the market opens on Thursday, October 29 th , 2015, and will follow with a conference call to discuss the results and business

MADRID , Oct. 13, 2015 /PRNewswire/ -- (Booth #4G30) -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative systems and component solutions for injectable drug administration, today launched Daikyo RUV® (ready-to-use/validated) components at CPhI Worldwide/InnoPack Europe

EXTON, Pa. , Sept. 30, 2015 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced it has appointed Annette Favorite to serve as Senior Vice President and Chief Human Resources Officer, effective

Connected health leaders complete first two phases of medication adherence collaboration EXTON, Pa. , Sept. 17, 2015 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) and HealthPrize Technologies, LLC , today announced the completion of the first two phases of their four-phase

Reduces Pension Obligation by 44% EXTON, PA -- ( Marketwired ) -- 09/10/15 -- West Pharmaceutical Services, Inc. ("West") (NYSE: WST) today announced that it has entered into an agreement to purchase a group life annuity contract from Metropolitan Life Insurance Company ( MetLife ) to settle

EXTON, PA -- ( Marketwired ) -- 09/02/15 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will participate in two upcoming investor conferences. Management will be presenting an overview of West's business and outlook at each of the following conferences: CL King's

Delivers Sales of $359.7 Million and Adjusted Diluted EPS of $0.47. Raises Lower-End of Full-Year 2015 Adjusted Diluted EPS to a New Range of $1.74 to $1.84 -- Conference Call Scheduled for 9 a.m. Today EXTON, PA -- ( Marketwired ) -- 07/30/15 -- West Pharmaceutical Services, Inc.

EXTON, PA -- ( Marketwired ) -- 07/23/15 -- West Pharmaceutical Services, Inc. (NYSE: WST) announced today that it will release second quarter 2015 financial results before the market opens on Thursday, July 30, 2015 , and will follow with a conference call to discuss the results and business

Patient-friendly wearable injector utilized in multiple active drug development programs EXTON, Pa. , July 20, 2015 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it has

EXTON, PA -- ( Marketwired ) -- 07/14/15 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a fourth-quarter 2015 dividend of $0.12 per share, a 9.1% increase over the $0.11 per share declared for each of the four preceding quarters.

EXTON, PA -- ( Marketwired ) -- 07/01/15 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company will pay a third-quarter 2015 dividend of $0.11 per share. The dividend will be paid on August 5, 2015 to shareholders of record as of July 22, 2015 .